ROI & Integration

The Business Case
for Guided Dentistry

BioUView is not just a better clinical tool — it is a practice-building platform that generates new revenue, reduces costly complications, and differentiates your practice in a competitive market.

Calculate Your Practice ROI

Adjust the sliders to match your patient volume and see your projected return.

Practice ROI Estimator

1040 patients/mo200
5%30% (12 patients)80%
$4,520
Additional Monthly Revenue
Enhanced billing + failure reduction
$54,240
Projected Annual ROI
Conservative estimate
2 mo
Estimated Payback Period
At mid-tier device price
12
Implant Patients Protected
Per month with guided care

* Estimates based on $85/patient enhanced visualization billing + 40% implant failure reduction at $2,800 avg retreatment cost. Actual results vary.

Three Revenue Streams

BioUView creates value across the entire practice — from hygiene to implant maintenance to case acceptance.

01

Enhanced Visualization Billing

Fluorescence-guided procedures justify enhanced billing codes for adjunctive diagnostic services (D0190) and comprehensive intraoral series (D0210). At $85 per patient, a practice seeing 40 perio/implant patients per month generates an additional $3,400/month from billing alone.

$85/patient
Additional billing potential
02

Implant Failure Prevention

The average cost of implant failure and retreatment is $2,800–$5,000 per case. Early studies project a 40% reduction in implant failure callbacks with fluorescence-guided maintenance. For a practice with 12 implant patients per month, this represents $13,440/month in prevented costs and liability.

40%
Reduction in implant failure callbacks
03

Case Acceptance & Differentiation

When patients see glowing biofilm on the screen in real time, case acceptance for recommended treatment approaches 100%. BioUView also differentiates your practice as a technology leader — a powerful marketing asset for attracting new patients and retaining existing ones.

~100%
Case acceptance when patients see biofilm
DSO & Group Practice

The New Standard
for Peri-Implant Care

For Dental Service Organizations managing quality control across hundreds of clinics, BioUView provides a standardized, evidence-based protocol for high-value peri-implant maintenance. The US DSO market is projected at over $155 billion in 2025 — and peri-implantitis management is one of its fastest-growing challenges.

BioUView's digital documentation capability — before/after fluorescence images captured for every procedure — provides the audit trail and quality assurance that DSO management teams require. It transforms a subjective, clinician-dependent procedure into an objective, measurable, and standardizable protocol.

$155B+
US DSO Market Size
2025 projection
$1.16B
Peri-Implantitis Market
2025, growing at 9% CAGR
$5.45B
Implant Market (Global)
2026 projection
$4K–$8K
BioUView Target ASP
Per unit, premium tier

Seamless Integration

BioUView is designed to integrate into your existing operatory workflow with minimal disruption and maximum impact.

🎓

2-Hour Certification

A structured online certification program for hygienists and dentists covers joystick control, fluorescence interpretation, and documentation protocols. No extended training period required.

🔌

Existing Operatory Compatible

BioUView connects to your existing monitor or tablet. No dedicated cart or room required. The compact console fits on any counter surface.

🧪

Validated Sterilization Protocol

A fully validated sterilization protocol for the articulating probe — including compatible sheaths and low-temperature sterilization methods — is provided with every system.

🛡️

UV Safety Compliance

UV-blocking eye shields for both patient and operator are included with every system. Full safety guidelines and compliance documentation are provided.